Schoemaker R C, van Gerven J M, Cohen A F
Centre for Human Drug Research, Leiden, The Netherlands.
J Pharmacokinet Biopharm. 1998 Oct;26(5):581-93. doi: 10.1023/a:1023277201179.
The most widely applied model relating drug concentrations to effects is the Emax model. In practice, concentration-effect relationships often deviate from a simple linear relationship but without reaching a clear maximum because a further increase in concentration might be associated with unacceptable or distorting side effects. The parameters for the Emax model can only be estimated with reasonable precision if the curve shows sign of reaching a maximum, otherwise both EC50 and Emax estimates may be extremely imprecise. This paper provides a solution by introducing a new parameter (S0) equal to Emax/EC50 that can be used to characterize potency adequately even if there are no signs of a clear maximum. Simulations are presented to investigate the nature of the new parameter and published examples are used as illustration.
将药物浓度与效应相关联的应用最广泛的模型是Emax模型。在实际应用中,浓度-效应关系常常偏离简单的线性关系,却又未达到明确的最大值,因为浓度的进一步升高可能会伴有不可接受的或扭曲性的副作用。只有当曲线显示出达到最大值的迹象时,Emax模型的参数才能以合理的精度进行估计,否则,半数效应浓度(EC50)和最大效应(Emax)的估计值可能都极不精确。本文通过引入一个新参数(S0)来提供一种解决方案,该参数等于Emax/EC50,即使没有明确最大值的迹象,它也可用于充分表征效价。文中给出了模拟结果以研究新参数的性质,并使用已发表的实例作为说明。